At a glance
- Originator Nonindustrial source
- Class Anthraquinones; Antibacterials; Antineoplastics; Small molecules
- Mechanism of Action DNA synthesis inhibitors; Protein synthesis inhibitors; Protein tyrosine kinase inhibitors; RNA synthesis inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer